ID   ATPB_HUMAN              Reviewed;         529 AA.
AC   P06576; A8K4X0; Q14283;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 3.
DT   28-JAN-2026, entry version 263.
DE   RecName: Full=ATP synthase F(1) complex subunit beta, mitochondrial {ECO:0000305};
DE            EC=7.1.2.2 {ECO:0000305|PubMed:25168243};
DE   AltName: Full=ATP synthase F1 subunit beta {ECO:0000312|HGNC:HGNC:830};
DE   Flags: Precursor;
GN   Name=ATP5F1B {ECO:0000312|HGNC:HGNC:830};
GN   Synonyms=ATP5B {ECO:0000312|HGNC:HGNC:830}, ATPMB, ATPSB
GN   {ECO:0000312|HGNC:HGNC:830};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2687158; DOI=10.1016/0888-7543(89)90125-0;
RA   Neckelmann N., Warner C.K., Chung A., Kudoh J., Minoshima S., Fukuyama R.,
RA   Maekawa M., Shimizu Y., Shimizu N., Liu J.D., Wallace D.C.;
RT   "The human ATP synthase beta subunit gene: sequence analysis, chromosome
RT   assignment, and differential expression.";
RL   Genomics 5:829-843(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-274.
RX   PubMed=2900241; DOI=10.1016/s0021-9258(18)37950-x;
RA   Ohta S., Tomura H., Matsuda K., Kagawa Y.;
RT   "Gene structure of the human mitochondrial adenosine triphosphate synthase
RT   beta subunit.";
RL   J. Biol. Chem. 263:11257-11262(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-274.
RX   PubMed=2870059; DOI=10.1093/oxfordjournals.jbchem.a135452;
RA   Ohta S., Kagawa Y.;
RT   "Human F1-ATPase: molecular cloning of cDNA for the beta subunit.";
RL   J. Biochem. 99:135-141(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 48-63.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective labeling of
RT   protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [8]
RP   PROTEIN SEQUENCE OF 95-121; 125-155; 189-198; 202-239; 242-259; 265-279;
RP   282-345; 388-422; 433-456 AND 490-519, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 218-529.
RX   PubMed=2896550; DOI=10.1007/bf00434661;
RA   Wallace D.C., Ye J., Neckelmann S.N., Singh G., Webster K.A.,
RA   Greenberg B.D.;
RT   "Sequence analysis of cDNAs for the human and bovine ATP synthase beta
RT   subunit: mitochondrial DNA genes sustain seventeen times more mutations.";
RL   Curr. Genet. 12:81-90(1987).
RN   [10]
RP   PROTEIN SEQUENCE OF 95-109; 282-294 AND 311-324.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/bj20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at the
RT   surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 95-121; 125-155; 162-188; 202-239; 242-259; 265-279;
RP   282-345; 407-422 AND 463-480, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-133; LYS-198 AND LYS-426, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415 AND SER-529, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUBCELLULAR LOCATION, INTERACTION WITH TTC5, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=25168243; DOI=10.1038/cdd.2014.135;
RA   Maniam S., Coutts A.S., Stratford M.R., McGouran J., Kessler B.,
RA   La Thangue N.B.;
RT   "Cofactor Strap regulates oxidative phosphorylation and mitochondrial p53
RT   activity through ATP synthase.";
RL   Cell Death Differ. 22:156-163(2015).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   INTERACTION WITH MTLN.
RX   PubMed=32243843; DOI=10.1016/j.stemcr.2020.03.002;
RA   Friesen M., Warren C.R., Yu H., Toyohara T., Ding Q., Florido M.H.C.,
RA   Sayre C., Pope B.D., Goff L.A., Rinn J.L., Cowan C.A.;
RT   "Mitoregulin Controls beta-Oxidation in Human and Mouse Adipocytes.";
RL   Stem Cell Reports 14:590-602(2020).
RN   [20] {ECO:0007744|PDB:8H9E, ECO:0007744|PDB:8H9I, ECO:0007744|PDB:8H9L, ECO:0007744|PDB:8H9P, ECO:0007744|PDB:8H9S, ECO:0007744|PDB:8H9T, ECO:0007744|PDB:8H9U, ECO:0007744|PDB:8H9V}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.53 ANGSTROMS) OF 48-529 IN COMPLEX WITH
RP   ADP AND MG(2+), IDENTIFICATION IN THE ATP SYNTHASE COMPLEX, FUNCTION,
RP   CATALYTIC ACTIVITY, COFACTOR, AND SUBUNIT.
RX   PubMed=37244256; DOI=10.1016/j.molcel.2023.04.029;
RA   Lai Y., Zhang Y., Zhou S., Xu J., Du Z., Feng Z., Yu L., Zhao Z., Wang W.,
RA   Tang Y., Yang X., Guddat L.W., Liu F., Gao Y., Rao Z., Gong H.;
RT   "Structure of the human ATP synthase.";
RL   Mol. Cell 83:2137-2147.e4(2023).
RN   [21]
RP   INVOLVEMENT IN HUMOP2, VARIANT HUMOP2 PRO-335, FUNCTION, AND
RP   CHARACTERIZATION OF VARIANT HUMOP2 PRO-335.
RX   PubMed=36239646; DOI=10.1056/nejmoa2202949;
RA   Ganetzky R.D., Markhard A.L., Yee I., Clever S., Cahill A., Shah H.,
RA   Grabarek Z., To T.L., Mootha V.K.;
RT   "Congenital hypermetabolism and uncoupled oxidative phosphorylation.";
RL   N. Engl. J. Med. 387:1395-1403(2022).
RN   [22]
RP   VARIANT VAL-130.
RX   PubMed=25787250; DOI=10.1073/pnas.1503696112;
RA   Cromer M.K., Choi M., Nelson-Williams C., Fonseca A.L., Kunstman J.W.,
RA   Korah R.M., Overton J.D., Mane S., Kenney B., Malchoff C.D., Stalberg P.,
RA   Akerstroem G., Westin G., Hellman P., Carling T., Bjoerklund P.,
RA   Lifton R.P.;
RT   "Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in
RT   insulin-producing adenomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:4062-4067(2015).
CC   -!- FUNCTION: Catalytic subunit beta, of the mitochondrial membrane ATP
CC       synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP
CC       from ADP in the presence of a proton gradient across the membrane which
CC       is generated by electron transport complexes of the respiratory chain
CC       (Probable) (PubMed:37244256). ATP synthase complex consist of a soluble
CC       F(1) head domain - the catalytic core - and a membrane F(1) domain
CC       - the membrane proton channel (PubMed:37244256). These two domains are
CC       linked by a central stalk rotating inside the F(1) region and a
CC       stationary peripheral stalk (PubMed:37244256). During catalysis, ATP
CC       synthesis in the catalytic domain of F(1) is coupled via a rotary
CC       mechanism of the central stalk subunits to proton translocation
CC       (Probable). In vivo, can only synthesize ATP although its ATP hydrolase
CC       activity can be activated artificially in vitro (By similarity). With
CC       the subunit alpha (ATP5F1A), forms the catalytic core in the F(1)
CC       domain (PubMed:37244256). {ECO:0000250|UniProtKB:P19483,
CC       ECO:0000269|PubMed:37244256, ECO:0000305|PubMed:25168243,
CC       ECO:0000305|PubMed:36239646, ECO:0000305|PubMed:37244256}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + 4 H(+)(in) = ADP + phosphate + 5 H(+)(out);
CC         Xref=Rhea:RHEA:57720, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=7.1.2.2;
CC         Evidence={ECO:0000305|PubMed:25168243, ECO:0000305|PubMed:37244256};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:57722;
CC         Evidence={ECO:0000305|PubMed:25168243, ECO:0000305|PubMed:37244256};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:37244256};
CC   -!- SUBUNIT: Homotrimer (PubMed:37244256). Component of the ATP synthase
CC       complex composed at least of ATP5F1A/subunit alpha, ATP5F1B/subunit
CC       beta, ATP5MC1/subunit c (homooctamer), MT-ATP6/subunit a, MT-
CC       ATP8/subunit 8, ATP5ME/subunit e, ATP5MF/subunit f, ATP5MG/subunit g,
CC       ATP5MK/subunit k, ATP5MJ/subunit j, ATP5F1C/subunit gamma,
CC       ATP5F1D/subunit delta, ATP5F1E/subunit epsilon, ATP5PF/subunit F6,
CC       ATP5PB/subunit b, ATP5PD/subunit d, ATP5PO/subunit OSCP
CC       (PubMed:37244256). ATP synthase complex consists of a soluble F(1) head
CC       domain (subunits alpha(3) and beta(3)) - the catalytic core - and a
CC       membrane F(0) domain - the membrane proton channel (subunits c, a, 8,
CC       e, f, g, k and j) (PubMed:37244256). These two domains are linked by a
CC       central stalk (subunits gamma, delta, and epsilon) rotating inside the
CC       F1 region and a stationary peripheral stalk (subunits F6, b, d, and
CC       OSCP) (PubMed:37244256). Interacts with PPIF (By similarity). Interacts
CC       with BCL2L1 isoform BCL-X(L); the interaction mediates the association
CC       of BCL2L1 isoform BCL-X(L) with the mitochondrial membrane F(1)F(0) ATP
CC       synthase and enhances neurons metabolic efficiency (By similarity).
CC       Interacts with CLN5 and PPT1 (By similarity). Interacts with S100A1;
CC       this interaction increases F1-ATPase activity (By similarity).
CC       Interacts with MTLN (PubMed:32243843). Interacts with TTC5/STRAP; the
CC       interaction results in decreased mitochondrial ATP production
CC       (PubMed:25168243). {ECO:0000250|UniProtKB:P10719,
CC       ECO:0000250|UniProtKB:P56480, ECO:0000269|PubMed:25168243,
CC       ECO:0000269|PubMed:32243843, ECO:0000269|PubMed:37244256}.
CC   -!- INTERACTION:
CC       P06576; P25705: ATP5F1A; NbExp=8; IntAct=EBI-356231, EBI-351437;
CC       P06576; P36542: ATP5F1C; NbExp=3; IntAct=EBI-356231, EBI-711768;
CC       P06576; Q9UII2: ATP5IF1; NbExp=5; IntAct=EBI-356231, EBI-718459;
CC       P06576; O75947: ATP5PD; NbExp=3; IntAct=EBI-356231, EBI-724024;
CC       P06576; Q5TC12: ATPAF1; NbExp=4; IntAct=EBI-356231, EBI-1166891;
CC       P06576; Q8N5M1: ATPAF2; NbExp=9; IntAct=EBI-356231, EBI-1166928;
CC       P06576; P54253: ATXN1; NbExp=3; IntAct=EBI-356231, EBI-930964;
CC       P06576; Q13895: BYSL; NbExp=3; IntAct=EBI-356231, EBI-358049;
CC       P06576; P28566: HTR1E; NbExp=2; IntAct=EBI-356231, EBI-1043151;
CC       P06576; Q8N448: LNX2; NbExp=4; IntAct=EBI-356231, EBI-2340947;
CC       P06576; Q5T1Q4: SLC35F1; NbExp=3; IntAct=EBI-356231, EBI-13365456;
CC       P06576; P63104: YWHAZ; NbExp=2; IntAct=EBI-356231, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:25168243}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P00829}; Matrix side
CC       {ECO:0000250|UniProtKB:P00829, ECO:0000269|PubMed:25168243}.
CC   -!- DISEASE: Hypermetabolism due to uncoupled mitochondrial oxidative
CC       phosphorylation 2 (HUMOP2) [MIM:620085]: A disorder apparent in infancy
CC       and characterized by euthyroid hypermetabolism, failure to thrive
CC       despite excessive caloric intake, intermittent hyperthermia, and
CC       developmental delay. {ECO:0000269|PubMed:36239646}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ATPase alpha/beta chains family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27132; AAA51809.1; -; Genomic_DNA.
DR   EMBL; M19483; AAA51808.1; -; Genomic_DNA.
DR   EMBL; M19482; AAA51808.1; JOINED; Genomic_DNA.
DR   EMBL; X03559; CAA27246.1; -; mRNA.
DR   EMBL; D00022; BAA00016.1; -; mRNA.
DR   EMBL; AK291085; BAF83774.1; -; mRNA.
DR   EMBL; CH471054; EAW96952.1; -; Genomic_DNA.
DR   EMBL; BC016512; AAH16512.1; -; mRNA.
DR   EMBL; X05606; CAA29095.1; -; mRNA.
DR   CCDS; CCDS8924.1; -.
DR   PIR; A33370; A33370.
DR   RefSeq; NP_001677.2; NM_001686.3.
DR   PDB; 8H9E; EM; 2.53 A; D/E/F=48-529.
DR   PDB; 8H9I; EM; 2.77 A; D/E/F=48-529.
DR   PDB; 8H9L; EM; 2.61 A; D/E/F=48-529.
DR   PDB; 8H9P; EM; 3.02 A; D/E/F=48-529.
DR   PDB; 8H9S; EM; 2.53 A; D/E/F=48-529.
DR   PDB; 8H9T; EM; 2.77 A; D/E/F=48-529.
DR   PDB; 8H9U; EM; 2.61 A; D/E/F=48-529.
DR   PDB; 8H9V; EM; 3.02 A; D/E/F=48-529.
DR   PDB; 8KI3; EM; 2.89 A; D/E/F=48-529.
DR   PDBsum; 8H9E; -.
DR   PDBsum; 8H9I; -.
DR   PDBsum; 8H9L; -.
DR   PDBsum; 8H9P; -.
DR   PDBsum; 8H9S; -.
DR   PDBsum; 8H9T; -.
DR   PDBsum; 8H9U; -.
DR   PDBsum; 8H9V; -.
DR   PDBsum; 8KI3; -.
DR   AlphaFoldDB; P06576; -.
DR   EMDB; EMD-34564; -.
DR   EMDB; EMD-34568; -.
DR   EMDB; EMD-34572; -.
DR   EMDB; EMD-34576; -.
DR   EMDB; EMD-34580; -.
DR   EMDB; EMD-34581; -.
DR   EMDB; EMD-34582; -.
DR   EMDB; EMD-34583; -.
DR   EMDB; EMD-37251; -.
DR   SMR; P06576; -.
DR   BioGRID; 106994; 666.
DR   ComplexPortal; CPX-6151; Mitochondrial proton-transporting ATP synthase complex.
DR   CORUM; P06576; -.
DR   FunCoup; P06576; 2188.
DR   IntAct; P06576; 264.
DR   MINT; P06576; -.
DR   STRING; 9606.ENSP00000262030; -.
DR   ChEMBL; CHEMBL2062350; -.
DR   DrugBank; DB07384; 1-ACETYL-2-CARBOXYPIPERIDINE.
DR   DrugBank; DB07394; AUROVERTIN B.
DR   DrugBank; DB01119; Diazoxide.
DR   DrugBank; DB08949; Inositol nicotinate.
DR   DrugBank; DB08629; N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   DrugBank; DB08399; Piceatannol.
DR   DrugBank; DB04216; Quercetin.
DR   TCDB; 3.A.2.1.15; the h+- or na+-translocating f-type, v-type and a-type atpase (f-atpase) superfamily.
DR   CarbonylDB; P06576; -.
DR   GlyCosmos; P06576; 2 sites, 1 glycan.
DR   GlyGen; P06576; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P06576; -.
DR   MetOSite; P06576; -.
DR   PhosphoSitePlus; P06576; -.
DR   SwissPalm; P06576; -.
DR   BioMuta; ATP5B; -.
DR   DMDM; 114549; -.
DR   OGP; P06576; -.
DR   REPRODUCTION-2DPAGE; IPI00303476; -.
DR   REPRODUCTION-2DPAGE; P06576; -.
DR   CPTAC; CPTAC-315; -.
DR   CPTAC; CPTAC-316; -.
DR   jPOST; P06576; -.
DR   MassIVE; P06576; -.
DR   PaxDb; 9606-ENSP00000262030; -.
DR   PeptideAtlas; P06576; -.
DR   PRIDE; P06576; -.
DR   ProteomicsDB; 51907; -.
DR   Pumba; P06576; -.
DR   TopDownProteomics; P06576; -.
DR   Antibodypedia; 877; 568 antibodies from 37 providers.
DR   DNASU; 506; -.
DR   Ensembl; ENST00000262030.8; ENSP00000262030.3; ENSG00000110955.10.
DR   GeneID; 506; -.
DR   KEGG; hsa:506; -.
DR   MANE-Select; ENST00000262030.8; ENSP00000262030.3; NM_001686.4; NP_001677.2.
DR   AGR; HGNC:830; -.
DR   ClinPGx; PA25122; -.
DR   CTD; 506; -.
DR   DisGeNET; 506; -.
DR   GeneCards; ATP5F1B; -.
DR   HGNC; HGNC:830; ATP5F1B.
DR   HPA; ENSG00000110955; Tissue enhanced (skeletal muscle, tongue).
DR   MalaCards; ATP5F1B; -.
DR   MIM; 102910; gene.
DR   MIM; 620085; phenotype.
DR   OpenTargets; ENSG00000110955; -.
DR   VEuPathDB; HostDB:ENSG00000110955; -.
DR   eggNOG; KOG1350; Eukaryota.
DR   GeneTree; ENSGT00550000074800; -.
DR   HOGENOM; CLU_022398_0_2_1; -.
DR   InParanoid; P06576; -.
DR   OMA; SMEEGGW; -.
DR   OrthoDB; 14523at2759; -.
DR   PAN-GO; P06576; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; P06576; -.
DR   BioCyc; MetaCyc:HS03358-MONOMER; -.
DR   PathwayCommons; P06576; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-163210; Formation of ATP by chemiosmotic coupling.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-8949613; Cristae formation.
DR   Reactome; R-HSA-9837999; Mitochondrial protein degradation.
DR   SignaLink; P06576; -.
DR   SIGNOR; P06576; -.
DR   Agora; ENSG00000110955; -.
DR   BioGRID-ORCS; 506; 586 hits in 1170 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; ATP5B; human.
DR   GeneWiki; ATP5B; -.
DR   GenomeRNAi; 506; -.
DR   Pharos; P06576; Tbio.
DR   PRO; PR:P06576; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P06576; protein.
DR   Bgee; ENSG00000110955; Expressed in apex of heart and 200 other cell types or tissues.
DR   ExpressionAtlas; P06576; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:CAFA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; NAS:ComplexPortal.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProtKB.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045259; C:proton-transporting ATP synthase complex; IDA:UniProtKB.
DR   GO; GO:0043532; F:angiostatin binding; IPI:CAFA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042288; F:MHC class I protein binding; IDA:UniProtKB.
DR   GO; GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IDA:UniProtKB.
DR   GO; GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IMP:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IMP:UniProtKB.
DR   GO; GO:0006754; P:ATP biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0098761; P:cellular response to interleukin-7; IEA:Ensembl.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; NAS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:Ensembl.
DR   GO; GO:0006933; P:negative regulation of cell adhesion involved in substrate-bound cell migration; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IGI:CAFA.
DR   GO; GO:0015986; P:proton motive force-driven ATP synthesis; IDA:UniProtKB.
DR   GO; GO:0042776; P:proton motive force-driven mitochondrial ATP synthesis; IDA:UniProtKB.
DR   GO; GO:1902600; P:proton transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051453; P:regulation of intracellular pH; IMP:UniProtKB.
DR   CDD; cd18110; ATP-synt_F1_beta_C; 1.
DR   CDD; cd18115; ATP-synt_F1_beta_N; 1.
DR   CDD; cd01133; F1-ATPase_beta_CD; 1.
DR   FunFam; 1.10.1140.10:FF:000001; ATP synthase subunit beta; 1.
DR   FunFam; 2.40.10.170:FF:000004; ATP synthase subunit beta; 1.
DR   FunFam; 3.40.50.300:FF:000026; ATP synthase subunit beta; 1.
DR   Gene3D; 2.40.10.170; -; 1.
DR   Gene3D; 1.10.1140.10; Bovine Mitochondrial F1-atpase, Atp Synthase Beta Chain, Chain D, domain 3; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   HAMAP; MF_01347; ATP_synth_beta_bact; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR055190; ATP-synt_VA_C.
DR   InterPro; IPR005722; ATP_synth_F1_bsu.
DR   InterPro; IPR020003; ATPase_a/bsu_AS.
DR   InterPro; IPR050053; ATPase_alpha/beta_chains.
DR   InterPro; IPR004100; ATPase_F1/V1/A1_a/bsu_N.
DR   InterPro; IPR036121; ATPase_F1/V1/A1_a/bsu_N_sf.
DR   InterPro; IPR000194; ATPase_F1/V1/A1_a/bsu_nucl-bd.
DR   InterPro; IPR024034; ATPase_F1/V1_b/a_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR01039; atpD; 1.
DR   PANTHER; PTHR15184; ATP SYNTHASE; 1.
DR   PANTHER; PTHR15184:SF71; ATP SYNTHASE SUBUNIT BETA, MITOCHONDRIAL; 1.
DR   Pfam; PF00006; ATP-synt_ab; 1.
DR   Pfam; PF02874; ATP-synt_ab_N; 1.
DR   Pfam; PF22919; ATP-synt_VA_C; 1.
DR   PIRSF; PIRSF039072; ATPase_subunit_beta; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF47917; C-terminal domain of alpha and beta subunits of F1 ATP synthase; 1.
DR   SUPFAM; SSF50615; N-terminal domain of alpha and beta subunits of F1 ATP synthase; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00152; ATPASE_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP synthesis; ATP-binding; CF(1);
KW   Direct protein sequencing; Disease variant; Glycoprotein;
KW   Hydrogen ion transport; Ion transport; Magnesium; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion inner membrane; Nucleotide-binding;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Transit peptide; Translocase; Transport.
FT   TRANSIT         1..47
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:19892738"
FT   CHAIN           48..529
FT                   /note="ATP synthase F(1) complex subunit beta,
FT                   mitochondrial"
FT                   /id="PRO_0000002443"
FT   BINDING         209
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:37244256,
FT                   ECO:0007744|PDB:8H9V, ECO:0007744|PDB:8KI3"
FT   BINDING         209
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         209
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         210
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         210
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         211
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:37244256,
FT                   ECO:0007744|PDB:8H9V, ECO:0007744|PDB:8KI3"
FT   BINDING         211
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         211
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         212
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:37244256,
FT                   ECO:0007744|PDB:8H9V, ECO:0007744|PDB:8KI3"
FT   BINDING         212
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         212
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         213
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:37244256,
FT                   ECO:0007744|PDB:8H9V, ECO:0007744|PDB:8KI3"
FT   BINDING         213
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         213
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="ligand shared between two neighboring
FT                   subunits"
FT                   /evidence="ECO:0000269|PubMed:37244256,
FT                   ECO:0007744|PDB:8H9V, ECO:0007744|PDB:8KI3"
FT   BINDING         213
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         214
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:37244256,
FT                   ECO:0007744|PDB:8H9V, ECO:0007744|PDB:8KI3"
FT   BINDING         214
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         238
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="ligand shared between two neighboring
FT                   subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   BINDING         239
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00829"
FT   MOD_RES         124
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         124
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         133
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         133
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         161
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         161
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         198
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         259
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         259
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         264
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         264
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         312
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         426
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P10719"
FT   MOD_RES         480
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         485
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         522
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         522
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56480"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   CARBOHYD        106
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   VARIANT         130
FT                   /note="A -> V"
FT                   /evidence="ECO:0000269|PubMed:25787250"
FT                   /id="VAR_074188"
FT   VARIANT         274
FT                   /note="E -> Q (in dbSNP:rs1042001)"
FT                   /evidence="ECO:0000269|PubMed:2870059,
FT                   ECO:0000269|PubMed:2900241"
FT                   /id="VAR_048371"
FT   VARIANT         335
FT                   /note="L -> P (in HUMOP2; elevated baseline extracellular
FT                   acidification rate; increased glucose consumption;
FT                   increased lactate release)"
FT                   /evidence="ECO:0000269|PubMed:36239646"
FT                   /id="VAR_087864"
FT   CONFLICT        1..6
FT                   /note="MLGFVG -> MTSLWGKGTGCKLFKF (in Ref. 3;
FT                   BAA00016/CAA27246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        36..40
FT                   /note="APTAV -> VRRRF (in Ref. 2; AAA51808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        36..40
FT                   /note="APTAV -> VRRRS (in Ref. 3; BAA00016/CAA27246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130..132
FT                   /note="API -> DQL (in Ref. 2; AAA51808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        378
FT                   /note="H -> D (in Ref. 2; AAA51808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        435
FT                   /note="Q -> H (in Ref. 2; AAA51808)"
FT                   /evidence="ECO:0000305"
FT   STRAND          60..67
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          70..77
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          85..90
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          96..104
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          107..114
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          124..127
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          129..131
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          133..137
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           138..140
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          161..166
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           173..175
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           188..193
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          201..204
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           212..226
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          231..238
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           240..252
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          265..271
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           276..295
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          300..306
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           309..321
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           335..343
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          353..359
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           363..365
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           370..376
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          379..383
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           388..391
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   TURN            400..402
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           410..437
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           450..464
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           469..471
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           472..475
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           484..495
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   TURN            496..499
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   STRAND          500..502
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           504..507
FT                   /evidence="ECO:0007829|PDB:8H9V"
FT   HELIX           513..521
FT                   /evidence="ECO:0007829|PDB:8H9V"
SQ   SEQUENCE   529 AA;  56560 MW;  960C616A2252B91A CRC64;
     MLGFVGRVAA APASGALRRL TPSASLPPAQ LLLRAAPTAV HPVRDYAAQT SPSPKAGAAT
     GRIVAVIGAV VDVQFDEGLP PILNALEVQG RETRLVLEVA QHLGESTVRT IAMDGTEGLV
     RGQKVLDSGA PIKIPVGPET LGRIMNVIGE PIDERGPIKT KQFAPIHAEA PEFMEMSVEQ
     EILVTGIKVV DLLAPYAKGG KIGLFGGAGV GKTVLIMELI NNVAKAHGGY SVFAGVGERT
     REGNDLYHEM IESGVINLKD ATSKVALVYG QMNEPPGARA RVALTGLTVA EYFRDQEGQD
     VLLFIDNIFR FTQAGSEVSA LLGRIPSAVG YQPTLATDMG TMQERITTTK KGSITSVQAI
     YVPADDLTDP APATTFAHLD ATTVLSRAIA ELGIYPAVDP LDSTSRIMDP NIVGSEHYDV
     ARGVQKILQD YKSLQDIIAI LGMDELSEED KLTVSRARKI QRFLSQPFQV AEVFTGHMGK
     LVPLKETIKG FQQILAGEYD HLPEQAFYMV GPIEEAVAKA DKLAEEHSS
//
